Intensive care and drugs represent major sources of surcharges for NHIF
…are able to evaluate whether the innovative drugs are, indeed, effective. As decided earlier, in January, innovative drugs, and cancer medicines in particular, will be prescribed only at specific university hospitals which will be obliged to monitor the effects of the drugs on patients.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)